Off-Label Teplizumab Treatment for Adult-Onset Autoimmune Type 1 Diabetes Initially Misdiagnosed As Type 2 Diabetes: A Case Report
Cureus · 17.11.2026
DOI: 10.7759/cureus.119823 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 17.11.2026. Verfasst von Lilian A Maturell Rojas und 5 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rojas, L. A. M., Portilla, L. U., Suarez-Guerrero, Y., Castro, A., Rodriguez, A. M. V., & Ntim, K. (2026). Off-Label Teplizumab Treatment for Adult-Onset Autoimmune Type 1 Diabetes Initially Misdiagnosed As Type 2 Diabetes: A Case Report. Cureus. https://doi.org/10.7759/cureus.119823
Vancouver
Rojas LAM, Portilla LU, Suarez-Guerrero Y, Castro A, Rodriguez AMV, Ntim K. Off-Label Teplizumab Treatment for Adult-Onset Autoimmune Type 1 Diabetes Initially Misdiagnosed As Type 2 Diabetes: A Case Report. Cureus. 2026. doi:10.7759/cureus.119823
BibTeX
@article{Rojas2026,
author = {Rojas, Lilian A Maturell and Portilla, Lisset Urquiza and Suarez-Guerrero, Yoniel and Castro, Annabell and Rodriguez, Andy M Vinent and Ntim, Kwame},
title = {Off-Label Teplizumab Treatment for Adult-Onset Autoimmune Type 1 Diabetes Initially Misdiagnosed As Type 2 Diabetes: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.119823}
}
EUVIMED